Idarubicin is an anthracycline antineoplastic agent used in the treatment of acute myeloid leukemia (AML). It is effective in targeting rapidly dividing cancer cells by intercalating into DNA and inhibiting topoisomerase II, leading to DNA damage and apoptosis. Idarubicin is often used in combination with other chemotherapeutic agents to enhance its efficacy in treating leukemia. Its role in cancer therapy is critical, as it helps to control and potentially eradicate cancerous cells. In summary, Idarubicin is an important medication for managing acute myeloid leukemia.
Idarubicin intercalates into DNA and inhibits topoisomerase II, disrupting DNA replication and transcription, leading to cell death.
No published brands for this salt yet.